Physician

Indra Bole, MD

According to 2025 Medicare claims, Indra Bole, MD (NPI: 1518306885) practices advanced heart failure and transplant cardiology in the Columbus, OH market, with the plurality of this provider's patient population coming from Franklin, OH. This provider's primary affiliated billing organization is OSU INTERNAL MEDICINE, LLC (NPI: 1740231448; TIN: 311369596) and primary practice location at 43210-1240. Bole is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Bole's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 315 traditional Medicare patients, billed 758 HCPCS/CPT codes, and received $54,693 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,974 prescription claims across 267 beneficiaries totaling $504,654 in drug costs, led by Entresto (Sacubitril/Valsartan). DME data shows 144 claims. Open Payments data shows 5 records totaling $53,493. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $17,927 to $54,693. Similarly, Part D prescription costs have risen steadily, from $50,920 to $504,654. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $882 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	106	284	$17,927
2017	88	208	$15,234
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	95	189	$17,400
2022	447	745	$50,050
2023	464	944	$73,498
2024	315	758	$54,693

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	93	688	$50,920
2016	82	501	$80,029
2017	33	110	$8,182
2018	11	62	$6,950
2019	18	97	$14,152
2020	24	85	$12,045
2021	51	146	$51,382
2022	95	551	$112,393
2023	182	1,127	$264,941
2024	267	1,974	$504,654

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	12	$277
2016	N/R	43	$1,172
2017	N/R	24	$920
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	23	$356
2023	N/R	52	$846
2024	N/R	144	$2,392

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	53	53	$120
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	64	204	$87
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	115	144	$84
99239	Hospital discharge day management, more than 30 minutes	34	37	$80
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	90	112	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Entresto	Sacubitril/Valsartan	98	7,306	$158,770
Jardiance	Empagliflozin	103	5,739	$107,502
Eliquis	Apixaban	61	4,163	$78,170
Farxiga	Dapagliflozin Propanediol	45	2,430	$43,623
Xarelto	Rivaroxaban	22	1,095	$19,260

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	41	$715
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	44	$639
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	25	$636
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	34	$401

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$1,151	One Lambda, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$52,341	PROCYRION, INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Indra Bole, MD?

Tedicare shows public-source Medicare data for Indra Bole, MD (NPI 1518306885), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Indra Bole, MD have ACO affiliation data?

Indra Bole, MD is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Indra Bole, MD?

Indra Bole, MD is linked to OSU INTERNAL MEDICINE, LLC (billing NPI 1740231448) in the available physician profile data.

Does Indra Bole, MD have Open Payments data?

Indra Bole, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.